Transcatheter Aortic Valve Replacement in Patients With Small Aortic Annulus: An Observational Study

Background: The Small Annuli Randomized to Evolut or SAPIEN Trial showed superior hemodynamics of self-expanding valves (SEVs) over balloon-expandable valves (BEVs) in patients with small aortic annuli (SAA). The long-term clinical implications of these hemodynamic differences are unknown. Methods:...

Full description

Saved in:
Bibliographic Details
Main Authors: Hanad Bashir, MD, Christian W. Schmidt, MS, Kofi Ansah, MD, Gustavo Mendez-Hirata, MD, Geoffrey A. Answini, MD, J. Michael Smith, MD, Saad Hasan, MD, Jeffrey Griffin, MD, Robert Dowling, MD, Dean J. Kereiakes, MD, Puvi Seshiah, MD, Joseph Choo, MD, Zaid Alirhayim, MD, Santiago Garcia, MD
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Structural Heart
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2474870624000861
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849705450505764864
author Hanad Bashir, MD
Christian W. Schmidt, MS
Kofi Ansah, MD
Gustavo Mendez-Hirata, MD
Geoffrey A. Answini, MD
J. Michael Smith, MD
Saad Hasan, MD
Jeffrey Griffin, MD
Robert Dowling, MD
Dean J. Kereiakes, MD
Puvi Seshiah, MD
Joseph Choo, MD
Zaid Alirhayim, MD
Santiago Garcia, MD
author_facet Hanad Bashir, MD
Christian W. Schmidt, MS
Kofi Ansah, MD
Gustavo Mendez-Hirata, MD
Geoffrey A. Answini, MD
J. Michael Smith, MD
Saad Hasan, MD
Jeffrey Griffin, MD
Robert Dowling, MD
Dean J. Kereiakes, MD
Puvi Seshiah, MD
Joseph Choo, MD
Zaid Alirhayim, MD
Santiago Garcia, MD
author_sort Hanad Bashir, MD
collection DOAJ
description Background: The Small Annuli Randomized to Evolut or SAPIEN Trial showed superior hemodynamics of self-expanding valves (SEVs) over balloon-expandable valves (BEVs) in patients with small aortic annuli (SAA). The long-term clinical implications of these hemodynamic differences are unknown. Methods: We conducted an observational cohort study of patients with SAA, defined as an aortic valve annular area ≤430 mm2 on cardiac computed tomography, who underwent transcatheter aortic valve replacement using BEV or SEV at a single institution between August 2013 and February 2021. Patients undergoing valve-in-valve procedures or alternative access were excluded. Patient-prosthesis mismatch (PPM) was defined as moderate when indexed effective orifice area of 0.65-0.85 cm2/m2 and severe when indexed effective orifice area was <0.65 cm2/m2 (or <0.55 cm2/m2 for body mass index >30 kg/m2). The primary outcome of the study was mortality and major adverse cardiovascular events. Results: A total of 258 patients were included. The majority were female (81%) with intermediate surgical risk (median STS risk score 4.23); 90 patients (35%) received a BEV (median age 80 years [73, 86]) and 168 (65%) received a SEV (81 years [75, 85], p = 0.699). Comorbidities and risk profiles were well balanced between groups. At 30 days post-transcatheter aortic valve replacement, SEV had lower aortic valve mean gradients (8 mmHg [6, 11] vs. BEV 14 mmHg [10, 18], p < 0.001), lower peak velocities (1.86 m/s [1.60, 2.34] vs. BEV 2.52 m/s [2.14, 2.90], p < 0.001), and were less likely to have PPM (SEV 18% vs. BEV 42% (p < 0.001). At 3 years, both groups had similar mortality (SEV 23% vs. BEV 22%, p = 0.875). PPM was not associated with long-term mortality. Conclusions: In patients with SAA, we observed no difference in mortality between SEV and BEV up to 3 years after the index procedure, despite early differences in valve hemodynamics.
format Article
id doaj-art-1d2032ce20bc4cfa97b2f6a9c456511e
institution DOAJ
issn 2474-8706
language English
publishDate 2025-02-01
publisher Elsevier
record_format Article
series Structural Heart
spelling doaj-art-1d2032ce20bc4cfa97b2f6a9c456511e2025-08-20T03:16:28ZengElsevierStructural Heart2474-87062025-02-019210033810.1016/j.shj.2024.100338Transcatheter Aortic Valve Replacement in Patients With Small Aortic Annulus: An Observational StudyHanad Bashir, MD0Christian W. Schmidt, MS1Kofi Ansah, MD2Gustavo Mendez-Hirata, MD3Geoffrey A. Answini, MD4J. Michael Smith, MD5Saad Hasan, MD6Jeffrey Griffin, MD7Robert Dowling, MD8Dean J. Kereiakes, MD9Puvi Seshiah, MD10Joseph Choo, MD11Zaid Alirhayim, MD12Santiago Garcia, MD13The Christ Hospital Heart and Vascular Institute and the Lindner Research Center, Cincinnati, OhioThe Christ Hospital Heart and Vascular Institute and the Lindner Research Center, Cincinnati, OhioThe Christ Hospital Heart and Vascular Institute and the Lindner Research Center, Cincinnati, OhioThe Christ Hospital Heart and Vascular Institute and the Lindner Research Center, Cincinnati, OhioThe Christ Hospital Heart and Vascular Institute and the Lindner Research Center, Cincinnati, OhioThe Christ Hospital Heart and Vascular Institute and the Lindner Research Center, Cincinnati, OhioThe Christ Hospital Heart and Vascular Institute and the Lindner Research Center, Cincinnati, OhioThe Christ Hospital Heart and Vascular Institute and the Lindner Research Center, Cincinnati, OhioThe Christ Hospital Heart and Vascular Institute and the Lindner Research Center, Cincinnati, OhioThe Christ Hospital Heart and Vascular Institute and the Lindner Research Center, Cincinnati, OhioThe Christ Hospital Heart and Vascular Institute and the Lindner Research Center, Cincinnati, OhioThe Christ Hospital Heart and Vascular Institute and the Lindner Research Center, Cincinnati, OhioThe Christ Hospital Heart and Vascular Institute and the Lindner Research Center, Cincinnati, OhioAddress correspondence to: Santiago Garcia, MD, FACC, FSCAI, Structural Heart Program and Harold C. Schott Foundation Endowed Chair for Structural and Valvular Heart Disease, The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital, 2139 Auburn Ave, Cincinnati, OH 45219.; The Christ Hospital Heart and Vascular Institute and the Lindner Research Center, Cincinnati, OhioBackground: The Small Annuli Randomized to Evolut or SAPIEN Trial showed superior hemodynamics of self-expanding valves (SEVs) over balloon-expandable valves (BEVs) in patients with small aortic annuli (SAA). The long-term clinical implications of these hemodynamic differences are unknown. Methods: We conducted an observational cohort study of patients with SAA, defined as an aortic valve annular area ≤430 mm2 on cardiac computed tomography, who underwent transcatheter aortic valve replacement using BEV or SEV at a single institution between August 2013 and February 2021. Patients undergoing valve-in-valve procedures or alternative access were excluded. Patient-prosthesis mismatch (PPM) was defined as moderate when indexed effective orifice area of 0.65-0.85 cm2/m2 and severe when indexed effective orifice area was <0.65 cm2/m2 (or <0.55 cm2/m2 for body mass index >30 kg/m2). The primary outcome of the study was mortality and major adverse cardiovascular events. Results: A total of 258 patients were included. The majority were female (81%) with intermediate surgical risk (median STS risk score 4.23); 90 patients (35%) received a BEV (median age 80 years [73, 86]) and 168 (65%) received a SEV (81 years [75, 85], p = 0.699). Comorbidities and risk profiles were well balanced between groups. At 30 days post-transcatheter aortic valve replacement, SEV had lower aortic valve mean gradients (8 mmHg [6, 11] vs. BEV 14 mmHg [10, 18], p < 0.001), lower peak velocities (1.86 m/s [1.60, 2.34] vs. BEV 2.52 m/s [2.14, 2.90], p < 0.001), and were less likely to have PPM (SEV 18% vs. BEV 42% (p < 0.001). At 3 years, both groups had similar mortality (SEV 23% vs. BEV 22%, p = 0.875). PPM was not associated with long-term mortality. Conclusions: In patients with SAA, we observed no difference in mortality between SEV and BEV up to 3 years after the index procedure, despite early differences in valve hemodynamics.http://www.sciencedirect.com/science/article/pii/S2474870624000861Balloon-expandable valvesPatient-prosthesis mismatchSelf-expanding valvesSmall aortic annuliTranscatheter aortic valve replacement
spellingShingle Hanad Bashir, MD
Christian W. Schmidt, MS
Kofi Ansah, MD
Gustavo Mendez-Hirata, MD
Geoffrey A. Answini, MD
J. Michael Smith, MD
Saad Hasan, MD
Jeffrey Griffin, MD
Robert Dowling, MD
Dean J. Kereiakes, MD
Puvi Seshiah, MD
Joseph Choo, MD
Zaid Alirhayim, MD
Santiago Garcia, MD
Transcatheter Aortic Valve Replacement in Patients With Small Aortic Annulus: An Observational Study
Structural Heart
Balloon-expandable valves
Patient-prosthesis mismatch
Self-expanding valves
Small aortic annuli
Transcatheter aortic valve replacement
title Transcatheter Aortic Valve Replacement in Patients With Small Aortic Annulus: An Observational Study
title_full Transcatheter Aortic Valve Replacement in Patients With Small Aortic Annulus: An Observational Study
title_fullStr Transcatheter Aortic Valve Replacement in Patients With Small Aortic Annulus: An Observational Study
title_full_unstemmed Transcatheter Aortic Valve Replacement in Patients With Small Aortic Annulus: An Observational Study
title_short Transcatheter Aortic Valve Replacement in Patients With Small Aortic Annulus: An Observational Study
title_sort transcatheter aortic valve replacement in patients with small aortic annulus an observational study
topic Balloon-expandable valves
Patient-prosthesis mismatch
Self-expanding valves
Small aortic annuli
Transcatheter aortic valve replacement
url http://www.sciencedirect.com/science/article/pii/S2474870624000861
work_keys_str_mv AT hanadbashirmd transcatheteraorticvalvereplacementinpatientswithsmallaorticannulusanobservationalstudy
AT christianwschmidtms transcatheteraorticvalvereplacementinpatientswithsmallaorticannulusanobservationalstudy
AT kofiansahmd transcatheteraorticvalvereplacementinpatientswithsmallaorticannulusanobservationalstudy
AT gustavomendezhiratamd transcatheteraorticvalvereplacementinpatientswithsmallaorticannulusanobservationalstudy
AT geoffreyaanswinimd transcatheteraorticvalvereplacementinpatientswithsmallaorticannulusanobservationalstudy
AT jmichaelsmithmd transcatheteraorticvalvereplacementinpatientswithsmallaorticannulusanobservationalstudy
AT saadhasanmd transcatheteraorticvalvereplacementinpatientswithsmallaorticannulusanobservationalstudy
AT jeffreygriffinmd transcatheteraorticvalvereplacementinpatientswithsmallaorticannulusanobservationalstudy
AT robertdowlingmd transcatheteraorticvalvereplacementinpatientswithsmallaorticannulusanobservationalstudy
AT deanjkereiakesmd transcatheteraorticvalvereplacementinpatientswithsmallaorticannulusanobservationalstudy
AT puviseshiahmd transcatheteraorticvalvereplacementinpatientswithsmallaorticannulusanobservationalstudy
AT josephchoomd transcatheteraorticvalvereplacementinpatientswithsmallaorticannulusanobservationalstudy
AT zaidalirhayimmd transcatheteraorticvalvereplacementinpatientswithsmallaorticannulusanobservationalstudy
AT santiagogarciamd transcatheteraorticvalvereplacementinpatientswithsmallaorticannulusanobservationalstudy